Interacting Drugs |
Butalbital compound and codeine vs Drotrecogin Alfa |
Security Level |
 |
Mechanism |
Drotrecogin Alfa: Salicylates may enhance the adverse/toxic effect of Drotrecogin Alfa. Bleeding may occur. |
Management |
Weigh potential benefits of drotrecogin against increased bleeding risk in patients who have received platelet inhibitors including aspirin (over 650 mg daily within 1 week). Monitor for bleeding and stop infusion if clinically important bleeding occurs. |
Butalbital compound and codeine vs Drotrecogin Alfa
Post Review about Butalbital compound and codeine vs Drotrecogin Alfa Click here to cancel reply.
Other Interactions of Butalbital compound and codeine
Other Interactions of Drotrecogin Alfa
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.